Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Quince Therapeutics Inc (NASDAQ: QNCX) closed at $0.95 down -7.77% from its previous closing price of $1.03. In other words, the price has decreased by -$7.77 from its previous closing price. On the day, 0.53 million shares were traded.
Ratios:
For a deeper understanding of Quince Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.05 and its Current Ratio is at 6.05. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on March 24, 2025, initiated with a Outperform rating and assigned the stock a target price of $10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 30 ’24 when Thye Dirk bought 77,000 shares for $0.70 per share. The transaction valued at 53,900 led to the insider holds 843,941 shares of the business.
Thye Dirk bought 77,500 shares of QNCX for $53,475 on Aug 29 ’24. The CEO AND CHIEF MEDICAL OFFICER now owns 766,941 shares after completing the transaction at $0.69 per share. On Aug 20 ’24, another insider, Ryan Charles S., who serves as the PRESIDENT of the company, bought 48,387 shares for $0.65 each. As a result, the insider paid 31,452 and bolstered with 122,461 shares of the company.
Stock Price History:
Over the past 52 weeks, QNCX has reached a high of $2.45, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is -22.07%, while the 200-Day Moving Average is calculated to be -24.84%.
Shares Statistics:
A total of 44.00M shares are outstanding, with a floating share count of 33.95M. Insiders hold about 23.05% of the company’s shares, while institutions hold 11.20% stake in the company.
